BCL2 and benign prostatic hyperplasia: As shown in the results, the expression of Bcl-2 from the BPH group significantly increased compared to the sham group (p < 0.01), while the expression of Bcl-2 from HT080 was significantly reduced in comparison with the BPH group (p < 0.01).